Glucagon-like Peptide-1 Receptor Agonists: A New Frontier in Treating Alcohol Use Disorder
Background/Objectives: Glucagon-like peptide-1 receptor agonists (GLP-1RAs), which were originally developed for managing type 2 diabetes by enhancing insulin secretion and reducing appetite, have emerged as promising candidates in alcohol use disorder (AUD). These medications offer a dual mechanism...
Gardado en:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI AG
2025-06-01
|
| Series: | Brain Sciences |
| Assuntos: | |
| Acceso en liña: | https://www.mdpi.com/2076-3425/15/7/702 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|